Moderna, Inc. today announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA, USA including more than doubling of space to transform the facility from a production and lab space to an industrial technology center.
This expansion includes increasing the Company’s production and lab space from approximately 300,000 square feet to approximately 650,000 square feet through renovation of existing space and acquisition of a 240,000 square foot building located on the same campus for expansion of its commercial and clinical activities.
This expansion will support a 50% increase in production of the Moderna COVID-19 Vaccine at Moderna’s manufacturing site, which is expected to ramp up in late 2021 and early 2022.
